Natural Alternatives International, Inc. last reported quarterly results on Aug 8, 2008, for the quarter ended Jun 30, 2008. It usually reports 15–39 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 15–39 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 8, 2008
39 days after quarter end
|
—
ended Jun 30, 2008
|
—
|
—
|
—
|
|
Oct 15, 2007
15 days after quarter end
|
—
ended Sep 30, 2007
|
—
|
—
|
—
|
|
Apr 30, 2007
30 days after quarter end
|
—
ended Mar 31, 2007
|
—
|
—
|
—
|
|
Jan 24, 2007
24 days after quarter end
|
—
ended Dec 31, 2006
|
—
|
—
|
—
|
|
Oct 23, 2006
23 days after quarter end
|
—
ended Sep 30, 2006
|
—
|
—
|
—
|
|
Jul 6, 2006
6 days after quarter end
|
—
ended Jun 30, 2006
|
—
|
—
|
—
|
|
May 1, 2006
31 days after quarter end
|
—
ended Mar 31, 2006
|
—
|
—
|
—
|
|
Feb 14, 2006
45 days after quarter end
|
—
ended Dec 31, 2005
|
—
|
—
|
—
|
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAII (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 787253
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.